Fig. 4From: Prognostic and clinicopathological significance of C-reactive protein in patients with ovarian cancer: a meta-analysisThe association between CRP and clinicopathological factors in patients with OC. A Age (years) (≥ 51 vs < 50). B FIGO stage (III–IV vs I–II). C Residual tumor size (cm) (≥ 1 vs < 1). D Histologic grade (3 vs 1–2). E Preoperative CA125 level (U/mL) (≥ 35 vs < 35). F Volume of ascites (mL) (≥ 500 vs < 500)Back to article page